MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Long-Term Dementia Risk in the General Parkinson Disease Population

    J. Maple-Grødem, ø. Rustan, D. Bäckström, M. Camacho, C. Counsell, I. Dalen, L. Forsgren, R. Lawson, A. Macleod, C. Williams-Gray, A. Yarnall, OB. Tysnes, G. Alves (Stavanger, Norway)

    Objective: To estimate the long-term risk of developing dementia in the general Parkinson’s disease (PD) population and to assess the influence of age at PD…
  • 2025 International Congress

    Mortality Trends Associated with Parkinson’s Disease with Diabetes Mellitus in the United States (1999-2020)

    T. Patel, R. Khan, M. Athar, S. Aleem, A. Khan, M. Altaf, A. Khan, M. Shahabi, B. Aslam, E. Zulfiqar, R. Millis, A. Awosika (Kingstown, Saint Vincent and the Grenadines)

    Objective: To assess the mortality trends and disparities associated with Parkinson’s disease in diabetic patients in the U.S. Background: Parkinson's disease (PD) is the second…
  • 2025 International Congress

    Metabolic dysfunction-associated steatotic liver disease, body mass index, and risk of Parkinson’s disease

    SJ. Chung, TS. Lim, J. Jeon, JK. Kim, J. Kim, PH. Lee (Seoul, Republic of Korea)

    Objective: This study aimed to investigate how metabolic dysfunction-associated steatotic liver disease (MASLD) and body mass index (BMI) together influence the incidence of Parkinson’s disease…
  • 2025 International Congress

    Comparison of clinical symptoms between young-onset and elderly-onset in patient with early Parkinson’s disease

    M. Iijima, R. Morimoto, K. Suzuki, S. Nogawa, Y. Okuma (Tokyo, Japan)

    Objective: We compared the clinical symptoms of early Parkinson's disease (PD) between young-onset and elderly-onset. Background: The progression of PD varies depending on the age…
  • 2025 International Congress

    Developing Disease-duration Specific Percentiles for Prospective Subtyping of the Diffuse Malignant Parkinson’s Disease: A PPMI-based study

    A. Negida, M. Barrett, SM. Fereshtehnejad, B. Berman, N. Mukhopadhyay (Toronto, Canada)

    Objective: To enable prospective identification of individuals with diffuse malignant (DM) Parkinson’s disease (PD) by establishing disease-duration-specific thresholds for motor and non-motor symptom scales. Background:…
  • 2025 International Congress

    The Relationship Between Demographic and Clinical Characteristics with Disease Severity and Quality of Life in Parkinson’s Patients

    R. Surbakti, A. Angelia, T. Lestarisa, A. Toemon, M. Anugerahny (Palangka Raya, Indonesia)

    Objective: To examine the relationship between demographic and clinical characteristics with Parkinson’s disease severity and quality of life, measured using the Hoehn & Yahr (H&Y)…
  • 2025 International Congress

    Temporal Trends in Parkinson’s Disease Related Mortality from 1999-2023: A National Analysis pre and post COVID

    N. Bujala, R. Shi, J. Javeid, Z. Xu, F. Yu (New York, USA)

    Objective: To examine the trends and impact of COVID-19 on Parkinson’s disease (PD) mortality stratified by gender, race and region among older adults in the…
  • 2025 International Congress

    Effect of Virtual Rehabilitation Therapy on Patients with Parkinson’s Disease: A Systematic Review and Meta-Analysis

    F. Luna-Rangel, B. Gonzalez-Bedolla, C. Armengol-Garcia, D. Martinez-Ramirez (Monterrey, Mexico)

    Objective: To assess the efficacy of virtual rehabilitation therapy compared to conventional physical therapy in patients with Parkinson’s disease. Background: Rehabilitation is essential in managing…
  • 2025 International Congress

    Multimodal Dissection of GALC Variants Linking Olfactory Deficits to Cognitive Decline in Parkinson’s Disease

    Y. Li, M. Zhong, J. Liu (shanghai, China)

    Objective: Olfactory dysfunction is highly prevalent and often precedes motor symptoms, making it a potential early biomarker for disease progression and cognitive decline in Parkinson's…
  • 2025 International Congress

    Analysis of statistical data on patients with Parkinson’s disease.

    R. Matmurodov, S. Jumanazarova, E. Abduqodirov, M. Abdullayeva (Tashkent, Uzbekistan)

    Objective: To determine the spread of the disease by sex and age groups among the population of Uzbekistan. Background: Parkinson's disease is quite relevant throughout…
  • « Previous Page
  • 1
  • …
  • 116
  • 117
  • 118
  • 119
  • 120
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley